Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
No major hospital changes
Health
May 23, 2026 Evan Vega

No confirmed major hospital industry merger, closure, or bankruptcy headline was available in the provided results

No major hospital mergers, closures, or bankruptcies were confirmed in early 2024, reflecting improved stability in the U.S. hospital industry.

Read More
No confirmed policy action
Health
May 23, 2026 Evan Vega

No confirmed CDC, FDA, or HHS policy action headline was available in the provided results

The CDC updated 2024 guidance allowing most asymptomatic healthcare workers with high-risk SARS-CoV-2 exposure to continue working without restrictions.

Read More
Americans worry healthcare costs
Health
May 23, 2026 Evan Vega

Americans’ top health care concern is affordability as new survey finds nearly half worry about costs heading into 2026

Nearly half of Americans worry about health care affordability in 2026, with 29% citing cost as the top health issue, per a West Health–Gallup survey.

Read More
Hospital systems increase outpatient
Health
May 22, 2026 Evan Vega

Major hospital systems accelerate outpatient migration as insurers and health systems strike new value-based care contracts

Major U.S. hospital systems accelerated outpatient care shifts in 2023 amid new value-based contracts promoting quality over volume.

Read More
Merck Kelun-Biotech lung cancer
Health
May 22, 2026 Evan Vega

Merck’s targeted Kelun-Biotech lung cancer drug sharply cut tumor progression risk in Phase 3 study

Merck and Kelun-Biotech’s Phase 3 trial showed sacituzumab tirumotecan plus KEYTRUDA cut tumor progression risk by 65% in advanced lung cancer patients.

Read More
Early antivirals reduce long COVID
Health
May 19, 2026 Evan Vega

New observational studies link early oral antiviral treatment to lower long COVID risk and better recovery after Omicron infection

Early oral antiviral treatment in COVID-19 outpatients linked to 14% lower risk of long COVID and faster recovery after Omicron infection.

Read More
Ebola outbreak spreads internationally
Health
May 19, 2026 Evan Vega

Ebola outbreak in Central Africa tops 131 deaths as U.S. doctor becomes a confirmed case, WHO and CDC intensify monitoring

Ebola outbreak in eastern DRC causes 131 deaths, 513 cases; U.S. doctor infected as WHO and CDC increase monitoring efforts.

Read More
Global health progress reversing
Health
May 19, 2026 Evan Vega

WHO warns global health gains are stalling as progress on maternal and child mortality, HIV, and neglected tropical diseases reverses

WHO reports stalled global health progress with rising maternal and child mortality, HIV setbacks, and reversed gains in neglected tropical diseases.

Read More
Hidden Muscle Fat Risks
Health
May 18, 2026 Evan Vega

Researchers Identify Hidden Muscle Fat as a New Risk Factor for Heart Disease and Metabolic Disorders

A 2026 study of 11,000 adults found hidden muscle fat linked to higher risks of heart disease and metabolic disorders, independent of body size.

Read More
Six-month Medicare enrollment freeze
Health
May 16, 2026 Evan Vega

CMS Imposes Six-Month Nationwide Moratorium on New Medicare Enrollment for Hospices and Home Health Agencies

CMS announces a six-month nationwide moratorium on new Medicare enrollments for hospices and home health agencies starting May 13, 2026.

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.